CCL11 and bipolar disorder: In line with the indirect findings implicating eotaxin-1/CCL11 in “accelerated aging” in bipolar disorder and schizophrenia, elevated plasma levels of eotaxin-1/CCL11 have been observed in neurodegenerative diseases, mainly Alzheimer's disease (42, 43).